ZENO - Zenosense, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development--32.215440.823
Selling General and Administrative158.912134.353114.261169.579
Non Recurring----
Total Operating Expenses158.912134.353146.476610.402
Operating Income or Loss-158.912-134.353-146.476-610.402
Income from Continuing Operations
Total Other Income/Expenses Net-407.382-115.009-3.729-0.268
Earnings Before Interest and Taxes-158.912-134.353-146.476-610.402
Interest Expense-252.417-71.845-3.729-0.268
Income Before Tax-566.294-249.362-150.205-610.67
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-566.294-249.362-150.205-610.67
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-566.294-249.362-150.205-610.67
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-566.294-249.362-150.205-610.67